Generation Bio
$32.759876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$32.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.88 (-5.43%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Generation Bio and other stocks, options, and ETFs commission-free!
About GBIO
Generation Bio Co. Common Stock, also called Generation Bio, is a genetic medicines company focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA. The listed name for GBIO is Generation Bio Co. Common Stock.
CEO
Cameron Geoffrey McDonough
Employees
85
Headquarters
Cambridge, Massachusetts
Founded
2016
Market Cap
2.06B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
427.66K
High Today
$35.77
Low Today
$29.23
Open Price
$35.58
Volume
569.46K
52 Week High
$55.72
52 Week Low
$17.00
Analyst Ratings
100%
of 6 ratings
Buy
100%
Hold
0%
Sell
0%
GBIO Earnings
-$1.50
-$1.00
-$0.50
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 10, Pre-Market